Clinical trial
Incidence of Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the Intensive Care Unit: a Retrospective Analysis
NCT04939753 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incidence of Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the Intensive Care Unit: a Retrospective Analysis
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 26, 2021
- Completion date
- April 1, 2023
- Enrollment
- 1,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nephrogenic diabetes insipidus